Altered Metabolism and Lipodystrophy in the Early B-Cell Factor 1-Deficient Mouse
Altered Metabolism and Lipodystrophy in the Early B-Cell Factor 1-Deficient Mouse
复制标题
DOI:
10.1210/en.2009-0987
复制
发表时间:
2010-04-01
期刊:
影响因子:
4.8
通讯作者:
Horowitz, Mark C.
中科院分区:
文献类型:
--
作者:
Fretz, Jackie A.;Nelson, Tracy;Horowitz, Mark C.
We previously reported that mice deficient for the transcription factor early B-cell factor (Ebf1) exhibit markedly increased numbers of osteoblasts, bone formation rate, and serum osteocalcin, but the bone marrow of Ebf1(-/-) mice is also striking in its increased marrow adiposity. The purpose of this work was to analyze the metabolic phenotype that accompanies the altered bone morphology of Ebf1(-/-) mice. Whereas marrow adiposity was increased, deposition of white adipose tissue in other regions of the body was severely reduced (sc 40-50%, abdominally 80-85%). Brown adipose exhibited decreased lipid deposition. Subcutaneous and perigonadal white adipose tissue showed a decrease in mRNA transcripts for peroxisomal proliferator-activated receptor-gamma 2 and CCAAT/enhancer-binding protein-beta in Ebf1(-/-) tissue compared with wild type. Circulating levels of leptin were decreased in Ebf1(-/-) animals compared with their littermate controls (down 65-95%), whereas adiponectin remained comparable after 2 wk of age. Serum analysis also found the Ebf1(-/-) animals were hypoglycemic and hypotriglyceridemic. After ip injection of insulin, the serum glucose levels in Ebf1(-/-) mice took longer to recover, and after a glucose challenge the Ebf1(-/-) animals reached serum glucose levels almost twice that of their wild-type counterparts. Measurement of circulating pancreatic hormones revealed normal or reduced insulin levels in the Ebf1(-/-) mice, whereas glucagon was significantly increased (up 1.7-to 8.5-fold). Metabolically the Ebf1(-/-) mice had increased O-2 consumption, CO2 production, food and water intake, and activity. Markers for gluconeogenesis, however, were decreased in the Ebf1(-/-) mice compared with controls. In conclusion, the Ebf1(-/-) deficient animals exhibit defects in adipose tissue deposition with increased marrow adiposity and impaired glucose mobilization. (Endocrinology 151: 1611-1621, 2010)